BRICS Securities puts BUY on Piramal Healthcare
BRICS Securities puts BUY on Piramal Healthcare
Piramal Healthcare’s (PHL) move to close down its API contract manufacturing facility at Huddersfield, UK is long-term positive.
While we expect the development to hurt FY10E revenue by 4% or Rs1.6bn, it would lead to higher operating margin in the long term.
We maintain a BUY recommendation with a revised price target of Rs273/share.
Click here to read a detailed report
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!